Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting
Department of Radiation Oncology, University of Alberta, Edmonton, Alberta, Canada
Dec
2019 (Vol.
26, Issue
6, Pages(
10045 - 10053)
PMID: 31860422